Document is current
Any future updates will be listed below
-
Authors
Stefan, Norbert https://orcid.org/0000-0002-2186-9595
Targher, Giovanni https://orcid.org/0000-0002-4325-3900
-
Funding
Funding for this research was provided by:
University of Verona School of Medicine, Verona, Italy
Deutsches Zentrum für Diabetesforschung
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 27 January 2026
Accepted: 6 May 2026
First Online: 17 July 2026
Ethics
Funding: Open Access funding enabled and organized by Projekt DEAL. This work was aided in part by funding from the German Center for Diabetes Research (DZD) to NS. GT is supported in part by the University of Verona School of Medicine, Verona, Italy.
Authors’ relationships and activities: NS has been or is a consultant and has given scientific talks for Allergan, AstraZeneca, Boehringer Ingelheim, Gilead, Genkyotex, GSK, Intercept Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer and Sanofi. NS has also received research support from AstraZeneca, Boehringer Ingelheim, Sanofi, DSM Nutritional Products and Roche Diagnostics. GT declares that there are no relationships or activities that might bias, or be perceived to bias, his work.
Contribution statement: Both authors were responsible for drafting and critically reviewing the article. Both authors approved the version to be published.
